2024-10-24 23:05:06,850 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:06,851 - INFO - Run 0:
**INT. NEWS STUDIO - DAY (AUGUST 24, 2024)**

*NATE SILVER and PHILIP TETLOCK sit across from each other, papers in hand.*

**NATE SILVER:** Well, it's the day after, and the CDC has not confirmed a Clade I mpox case in a U.S. resident.

**PHILIP TETLOCK:** Right, Nate. Our models had it at 15.32%. Despite the CDC's alert and the WHO's concern, it seems the virus stayed contained in Africa.

**NATE SILVER:** The heightened awareness and travel advisories likely played a role. The risk was real, but the probability of a U.S. case was always low.

**PHILIP TETLOCK:** Exactly. The Clade I variant's severity demanded caution, but our data showed limited spread potential here.

**NATE SILVER:** Yet, it's a reminder of our interconnected world. We'll continue monitoring global health trends closely.

*They nod, acknowledging the complexity of predicting such events.*

**FADE OUT.**

2024-10-24 23:05:16,315 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:16,315 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:16,315 - INFO - Run 1:
**INT. NEWSROOM - DAY AFTER AUGUST 23, 2024**

*Nate Silver and Philip Tetlock sit at a round table, papers scattered, a screen displaying the CDC logo behind them.*

**NATE SILVER**  
Well, Philip, the CDC confirmed a case of Clade I mpox in the U.S. before the deadline. Our models had it at 65.75%.

**PHILIP TETLOCK**  
Yes, Nate. Given the recent alerts and increased travel from affected regions, it wasn't surprising. Our models factored in those risks.

**NATE SILVER**  
Indeed. The WHO's deliberation on declaring a public health emergency added weight. We anticipated a higher chance of spread.

**PHILIP TETLOCK**  
And yet, the severity of Clade I with its 4% fatality rate made vigilance key. We must continue refining our models.

**NATE SILVER**  
Absolutely. This event underscores the importance of predictive accuracy in public health.

*They exchange a knowing nod, the screen fades to black.*

2024-10-24 23:05:16,315 - INFO - Run 1:
**INT. NEWSROOM - DAY AFTER AUGUST 23, 2024**

*Nate Silver and Philip Tetlock sit at a round table, papers scattered, a screen displaying the CDC logo behind them.*

**NATE SILVER**  
Well, Philip, the CDC confirmed a case of Clade I mpox in the U.S. before the deadline. Our models had it at 65.75%.

**PHILIP TETLOCK**  
Yes, Nate. Given the recent alerts and increased travel from affected regions, it wasn't surprising. Our models factored in those risks.

**NATE SILVER**  
Indeed. The WHO's deliberation on declaring a public health emergency added weight. We anticipated a higher chance of spread.

**PHILIP TETLOCK**  
And yet, the severity of Clade I with its 4% fatality rate made vigilance key. We must continue refining our models.

**NATE SILVER**  
Absolutely. This event underscores the importance of predictive accuracy in public health.

*They exchange a knowing nod, the screen fades to black.*

2024-10-24 23:05:27,086 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:27,086 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:27,086 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:27,088 - INFO - Run 2:
**INT. NEWS STUDIO - DAY**

*NATE SILVER and PHILIP TETLOCK sit across from each other at a sleek news desk, papers scattered before them.*

**NATE SILVER:** So, the question on everyone's mind: Did the CDC confirm a Clade I mpox case in a U.S. resident before August 23, 2024? 

**PHILIP TETLOCK:** No, our models had it at 30.25%. Given the data up to August 14, the probability was low. Clade I remained contained within Africa, despite the CDC's alert.

**NATE SILVER:** Right. The alert was crucial, but without cases outside Africa by mid-August, the odds were against a U.S. confirmation. 

**PHILIP TETLOCK:** Exactly. Our models factored in the travel advisories and health protocols in place. 

**NATE SILVER:** Well, it's a relief, but it underscores the importance of vigilance. 

**PHILIP TETLOCK:** Agreed. Preparedness is key, even for low-probability events. 

*They nod, understanding the gravity of their predictions.*

**FADE OUT.**

2024-10-24 23:05:27,088 - INFO - Run 2:
**INT. NEWS STUDIO - DAY**

*NATE SILVER and PHILIP TETLOCK sit across from each other at a sleek news desk, papers scattered before them.*

**NATE SILVER:** So, the question on everyone's mind: Did the CDC confirm a Clade I mpox case in a U.S. resident before August 23, 2024? 

**PHILIP TETLOCK:** No, our models had it at 30.25%. Given the data up to August 14, the probability was low. Clade I remained contained within Africa, despite the CDC's alert.

**NATE SILVER:** Right. The alert was crucial, but without cases outside Africa by mid-August, the odds were against a U.S. confirmation. 

**PHILIP TETLOCK:** Exactly. Our models factored in the travel advisories and health protocols in place. 

**NATE SILVER:** Well, it's a relief, but it underscores the importance of vigilance. 

**PHILIP TETLOCK:** Agreed. Preparedness is key, even for low-probability events. 

*They nod, understanding the gravity of their predictions.*

**FADE OUT.**

2024-10-24 23:05:27,088 - INFO - Run 2:
**INT. NEWS STUDIO - DAY**

*NATE SILVER and PHILIP TETLOCK sit across from each other at a sleek news desk, papers scattered before them.*

**NATE SILVER:** So, the question on everyone's mind: Did the CDC confirm a Clade I mpox case in a U.S. resident before August 23, 2024? 

**PHILIP TETLOCK:** No, our models had it at 30.25%. Given the data up to August 14, the probability was low. Clade I remained contained within Africa, despite the CDC's alert.

**NATE SILVER:** Right. The alert was crucial, but without cases outside Africa by mid-August, the odds were against a U.S. confirmation. 

**PHILIP TETLOCK:** Exactly. Our models factored in the travel advisories and health protocols in place. 

**NATE SILVER:** Well, it's a relief, but it underscores the importance of vigilance. 

**PHILIP TETLOCK:** Agreed. Preparedness is key, even for low-probability events. 

*They nod, understanding the gravity of their predictions.*

**FADE OUT.**

2024-10-24 23:05:37,565 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:37,565 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:37,565 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:37,565 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:37,567 - INFO - Run 3:
**INT. NEWS STUDIO - DAY - AUGUST 24, 2024**

**NATE SILVER**  
(leaning back, reviewing notes)  
So, Philip, the CDC didn't confirm a Clade I mpox case in the U.S. by August 23. Given what we knew by August 14, what did our models say?

**PHILIP TETLOCK**  
(nodding)  
No, our models had it at 15.75%. The strain was contained to central and eastern Africa, and travel advisories were effective.

**NATE SILVER**  
Right. The CDC's alert was precautionary. Clade I's severity made it crucial to stay vigilant, but our data showed low transmission probability here.

**PHILIP TETLOCK**  
Precisely. The 2022-2023 outbreak was Clade II, less severe. Clade I's nearly 4% fatality rate raised alarms, but no U.S. cases confirmed.

**NATE SILVER**  
(leaning forward)  
Staying ahead is key. Our models continue to guide us through these uncertainties.

2024-10-24 23:05:37,567 - INFO - Run 3:
**INT. NEWS STUDIO - DAY - AUGUST 24, 2024**

**NATE SILVER**  
(leaning back, reviewing notes)  
So, Philip, the CDC didn't confirm a Clade I mpox case in the U.S. by August 23. Given what we knew by August 14, what did our models say?

**PHILIP TETLOCK**  
(nodding)  
No, our models had it at 15.75%. The strain was contained to central and eastern Africa, and travel advisories were effective.

**NATE SILVER**  
Right. The CDC's alert was precautionary. Clade I's severity made it crucial to stay vigilant, but our data showed low transmission probability here.

**PHILIP TETLOCK**  
Precisely. The 2022-2023 outbreak was Clade II, less severe. Clade I's nearly 4% fatality rate raised alarms, but no U.S. cases confirmed.

**NATE SILVER**  
(leaning forward)  
Staying ahead is key. Our models continue to guide us through these uncertainties.

2024-10-24 23:05:37,567 - INFO - Run 3:
**INT. NEWS STUDIO - DAY - AUGUST 24, 2024**

**NATE SILVER**  
(leaning back, reviewing notes)  
So, Philip, the CDC didn't confirm a Clade I mpox case in the U.S. by August 23. Given what we knew by August 14, what did our models say?

**PHILIP TETLOCK**  
(nodding)  
No, our models had it at 15.75%. The strain was contained to central and eastern Africa, and travel advisories were effective.

**NATE SILVER**  
Right. The CDC's alert was precautionary. Clade I's severity made it crucial to stay vigilant, but our data showed low transmission probability here.

**PHILIP TETLOCK**  
Precisely. The 2022-2023 outbreak was Clade II, less severe. Clade I's nearly 4% fatality rate raised alarms, but no U.S. cases confirmed.

**NATE SILVER**  
(leaning forward)  
Staying ahead is key. Our models continue to guide us through these uncertainties.

2024-10-24 23:05:37,567 - INFO - Run 3:
**INT. NEWS STUDIO - DAY - AUGUST 24, 2024**

**NATE SILVER**  
(leaning back, reviewing notes)  
So, Philip, the CDC didn't confirm a Clade I mpox case in the U.S. by August 23. Given what we knew by August 14, what did our models say?

**PHILIP TETLOCK**  
(nodding)  
No, our models had it at 15.75%. The strain was contained to central and eastern Africa, and travel advisories were effective.

**NATE SILVER**  
Right. The CDC's alert was precautionary. Clade I's severity made it crucial to stay vigilant, but our data showed low transmission probability here.

**PHILIP TETLOCK**  
Precisely. The 2022-2023 outbreak was Clade II, less severe. Clade I's nearly 4% fatality rate raised alarms, but no U.S. cases confirmed.

**NATE SILVER**  
(leaning forward)  
Staying ahead is key. Our models continue to guide us through these uncertainties.

2024-10-24 23:05:45,416 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:45,416 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:45,416 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:45,416 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:45,416 - INFO - Question: Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024?
2024-10-24 23:05:45,417 - INFO - Run 4:
**INT. NEWS STUDIO - DAY**

*The camera pans to NATE SILVER and PHILIP TETLOCK seated at a desk, papers scattered around.*

**NATE SILVER**  
Well, Philip, the deadline has passed. Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024? Our models had it at 15.75%.

**PHILIP TETLOCK**  
Indeed, Nate. Given the CDC's alert and the WHO's recent actions, the potential was there. But our data suggested a low likelihood of spread beyond Africa, and it seems we were correct.

**NATE SILVER**  
It's a relief, considering the severity of Clade I. Still, the global health community must remain vigilant.

**PHILIP TETLOCK**  
Absolutely. The interconnected world we live in means probabilities can shift quickly. But for now, it's a "No."

*The camera zooms out as they continue discussing future predictions.*

**FADE OUT.**

2024-10-24 23:05:45,417 - INFO - Run 4:
**INT. NEWS STUDIO - DAY**

*The camera pans to NATE SILVER and PHILIP TETLOCK seated at a desk, papers scattered around.*

**NATE SILVER**  
Well, Philip, the deadline has passed. Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024? Our models had it at 15.75%.

**PHILIP TETLOCK**  
Indeed, Nate. Given the CDC's alert and the WHO's recent actions, the potential was there. But our data suggested a low likelihood of spread beyond Africa, and it seems we were correct.

**NATE SILVER**  
It's a relief, considering the severity of Clade I. Still, the global health community must remain vigilant.

**PHILIP TETLOCK**  
Absolutely. The interconnected world we live in means probabilities can shift quickly. But for now, it's a "No."

*The camera zooms out as they continue discussing future predictions.*

**FADE OUT.**

2024-10-24 23:05:45,417 - INFO - Run 4:
**INT. NEWS STUDIO - DAY**

*The camera pans to NATE SILVER and PHILIP TETLOCK seated at a desk, papers scattered around.*

**NATE SILVER**  
Well, Philip, the deadline has passed. Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024? Our models had it at 15.75%.

**PHILIP TETLOCK**  
Indeed, Nate. Given the CDC's alert and the WHO's recent actions, the potential was there. But our data suggested a low likelihood of spread beyond Africa, and it seems we were correct.

**NATE SILVER**  
It's a relief, considering the severity of Clade I. Still, the global health community must remain vigilant.

**PHILIP TETLOCK**  
Absolutely. The interconnected world we live in means probabilities can shift quickly. But for now, it's a "No."

*The camera zooms out as they continue discussing future predictions.*

**FADE OUT.**

2024-10-24 23:05:45,417 - INFO - Run 4:
**INT. NEWS STUDIO - DAY**

*The camera pans to NATE SILVER and PHILIP TETLOCK seated at a desk, papers scattered around.*

**NATE SILVER**  
Well, Philip, the deadline has passed. Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024? Our models had it at 15.75%.

**PHILIP TETLOCK**  
Indeed, Nate. Given the CDC's alert and the WHO's recent actions, the potential was there. But our data suggested a low likelihood of spread beyond Africa, and it seems we were correct.

**NATE SILVER**  
It's a relief, considering the severity of Clade I. Still, the global health community must remain vigilant.

**PHILIP TETLOCK**  
Absolutely. The interconnected world we live in means probabilities can shift quickly. But for now, it's a "No."

*The camera zooms out as they continue discussing future predictions.*

**FADE OUT.**

2024-10-24 23:05:45,417 - INFO - Run 4:
**INT. NEWS STUDIO - DAY**

*The camera pans to NATE SILVER and PHILIP TETLOCK seated at a desk, papers scattered around.*

**NATE SILVER**  
Well, Philip, the deadline has passed. Will the CDC confirm a case of Clade I mpox in a US resident before August 23, 2024? Our models had it at 15.75%.

**PHILIP TETLOCK**  
Indeed, Nate. Given the CDC's alert and the WHO's recent actions, the potential was there. But our data suggested a low likelihood of spread beyond Africa, and it seems we were correct.

**NATE SILVER**  
It's a relief, considering the severity of Clade I. Still, the global health community must remain vigilant.

**PHILIP TETLOCK**  
Absolutely. The interconnected world we live in means probabilities can shift quickly. But for now, it's a "No."

*The camera zooms out as they continue discussing future predictions.*

**FADE OUT.**

